{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:11:00Z","timestamp":1767139860731,"version":"build-2238731810"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00059-024-05275-w","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T05:22:19Z","timestamp":1727155339000},"page":"135-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of sacubitril\u2013valsartan vs. angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in preventing atrial fibrillation recurrence after catheter ablation: a\u00a0systematic review and meta-analysis","Wirksamkeit von Sacubitril\u2013Valsartan vs. Angiotensin-Converting-Enzym-Hemmer oder Angiotensinrezeptorblocker zur Pr\u00e4vention rezidivierenden Vorhofflimmerns nach Katheterablation: systematische \u00dcbersichtsarbeit und Metaanalyse"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2587-4176","authenticated-orcid":false,"given":"Fernando","family":"Ba\u00eda Bezerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3006-5489","authenticated-orcid":false,"given":"Luis Eduardo","family":"Rodrigues Sobreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8317-1857","authenticated-orcid":false,"given":"Vitor Kendi","family":"Tsuchiya Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0637-0387","authenticated-orcid":false,"given":"Artur","family":"de Oliveira Macena L\u00f4bo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0316-8047","authenticated-orcid":false,"given":"Jorge Henrique","family":"Cavalcanti Orestes Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0706-6929","authenticated-orcid":false,"given":"Francinny","family":"Alves Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0623-8135","authenticated-orcid":false,"given":"Francisco Cezar","family":"Aquino de Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-019X","authenticated-orcid":false,"given":"Fernanda Marciano","family":"Consolim-Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"issue":"10","key":"5275_CR1","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.3390\/cells10102605","volume":"10","author":"A Goette","year":"2021","unstructured":"Goette\u00a0A, Lendeckel\u00a0U (2021) Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences. Cells 10(10):2605","journal-title":"Cells"},{"issue":"5","key":"5275_CR2","first-page":"437","volume":"74","author":"G Hindricks","year":"2020","unstructured":"Hindricks\u00a0G, Potpara\u00a0T, Dagres\u00a0N, Arbelo\u00a0E, Bax\u00a0JJ, Blomstr\u00f6m-Lundqvist\u00a0C et\u00a0al (2020) ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol 74(5):437","journal-title":"Rev Esp Cardiol"},{"issue":"35","key":"5275_CR3","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","volume":"34","author":"BP Krijthe","year":"2013","unstructured":"Krijthe\u00a0BP, Kunst\u00a0A, Benjamin\u00a0EJ, Lip\u00a0GYH, Franco\u00a0OH, Hofman\u00a0A et\u00a0al (2013) Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart\u00a0J 34(35):2746\u20132751","journal-title":"Eur Heart J"},{"key":"5275_CR4","doi-asserted-by":"crossref","unstructured":"Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S (2014) Epidemiology of atrial fibrillation: European perspective. CLEP 213:","DOI":"10.2147\/CLEP.S47385"},{"issue":"13","key":"5275_CR5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/jama.2019.0692","volume":"321","author":"DB Mark","year":"2019","unstructured":"Mark\u00a0DB, Anstrom\u00a0KJ, Sheng\u00a0S, Piccini\u00a0JP, Baloch\u00a0KN, Monahan\u00a0KH et\u00a0al (2019) Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA 321(13):1275\u20131272","journal-title":"JAMA"},{"issue":"11","key":"5275_CR6","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jama.2019.0335","volume":"321","author":"C Blomstr\u00f6m-Lundqvist","year":"2019","unstructured":"Blomstr\u00f6m-Lundqvist\u00a0C, Gizurarson\u00a0S, Schwieler\u00a0J, Jensen\u00a0SM, Bergfeldt\u00a0L, Kenneb\u00e4ck\u00a0G et\u00a0al (2019) Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial. JAMA 321(11):1059","journal-title":"JAMA"},{"issue":"2","key":"5275_CR7","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3892\/etm.2015.2545","volume":"10","author":"LZ Shi","year":"2015","unstructured":"Shi\u00a0LZ, Heng\u00a0R, Liu\u00a0SM, Leng\u00a0FY (2015) Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: A\u00a0meta-analysis of randomized controlled trials. Exp Ther Med 10(2):816\u2013822","journal-title":"Exp Ther Med"},{"issue":"4","key":"5275_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/clpt.2013.146","volume":"94","author":"O Vardeny","year":"2013","unstructured":"Vardeny\u00a0O, Tacheny\u00a0T, Solomon\u00a0SD (2013) First-in-Class Angiotensin Receptor Neprilysin Inhibitor in Heart Failure. Clin Pharmacol Ther 94(4):445\u2013448","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"5275_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/CRD.0000000000000093","volume":"24","author":"AM Sible","year":"2016","unstructured":"Sible\u00a0AM, Nawarskas\u00a0JJ, Alajajian\u00a0D, Anderson\u00a0JR (2016) Sacubitril\/Valsartan: A\u00a0Novel Cardiovascular Combination Agent. Cardiol Rev 24(1):41\u201347","journal-title":"Cardiol Rev"},{"issue":"31","key":"5275_CR10","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1093\/eurheartj\/ehad344","volume":"44","author":"M Vaduganathan","year":"2023","unstructured":"Vaduganathan\u00a0M, Mentz\u00a0RJ, Claggett\u00a0BL, Miao\u00a0ZM, Kulac\u00a0IJ, Ward\u00a0JH et\u00a0al (2023) Sacubitril\/valsartan in heart failure with mildly reduced or preserved ejection fraction: a\u00a0pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF. Eur Heart\u00a0J 44(31):2982\u20132993","journal-title":"Eur Heart J"},{"key":"5275_CR11","doi-asserted-by":"publisher","first-page":"173120","DOI":"10.1016\/j.ejphar.2020.173120","volume":"881","author":"LYF Li","year":"2020","unstructured":"Li\u00a0LYF, Lou\u00a0Q, Liu\u00a0GZ, Lv\u00a0JC, Yun\u00a0FX, Li\u00a0TK et\u00a0al (2020) Sacubitril\/valsartan attenuates atrial electrical and structural remodelling in a\u00a0rabbit model of atrial fibrillation. Eur J Pharmacol 881:173120","journal-title":"Eur J Pharmacol"},{"issue":"18","key":"5275_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/eurheartj\/eht507","volume":"35","author":"SCW Marott","year":"2014","unstructured":"Marott\u00a0SCW, Nielsen\u00a0SF, Benn\u00a0M, Nordestgaard\u00a0BG (2014) Antihypertensive treatment and risk of atrial fibrillation: a\u00a0nationwide study. Eur Heart\u00a0J 35(18):1205\u20131214","journal-title":"Eur Heart J"},{"issue":"1","key":"5275_CR13","doi-asserted-by":"publisher","first-page":"10328","DOI":"10.1038\/s41598-017-09675-3","volume":"7","author":"N Kim","year":"2017","unstructured":"Kim\u00a0N, Jung\u00a0Y, Nam\u00a0M, Kang\u00a0SM, Lee\u00a0MK, Cho\u00a0Y et\u00a0al (2017) Angiotensin\u00a0II affects inflammation mechanisms via AMPK-related signalling pathways in HL\u20111 atrial myocytes. Sci Rep 7(1):10328","journal-title":"Sci Rep"},{"issue":"4","key":"5275_CR14","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1002\/ehf2.13937","volume":"9","author":"L Yang","year":"2022","unstructured":"Yang\u00a0L, Zhang\u00a0M, Hao\u00a0Z, Wang\u00a0N, Zhang\u00a0M (2022) Sacubitril\/valsartan attenuates atrial structural remodelling in atrial fibrillation patients. Esc Heart Fail 9(4):2428\u20132434","journal-title":"Esc Heart Fail"},{"issue":"3","key":"5275_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10557-022-07315-1","volume":"37","author":"Q Wang","year":"2023","unstructured":"Wang\u00a0Q, Zhuo\u00a0C, Xia\u00a0Q, Jiang\u00a0J, Wu\u00a0B, Zhou\u00a0D et\u00a0al (2023) Sacubitril\/Valsartan Can Reduce Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation. Cardiovasc Drugs Ther 37(3):549\u2013560","journal-title":"Cardiovasc Drugs Ther"},{"key":"5275_CR16","doi-asserted-by":"publisher","first-page":"932780","DOI":"10.3389\/fcvm.2022.932780","volume":"9","author":"Y Dong","year":"2022","unstructured":"Dong\u00a0Y, Xiao\u00a0S, He\u00a0J, Shi\u00a0K, Chen\u00a0S, Liu\u00a0D et\u00a0al (2022) Angiotensin receptor-neprilysin inhibitor therapy and recurrence of atrial fibrillation after radiofrequency catheter ablation: A\u00a0propensity-matched cohort study. Front Cardiovasc Med 9:932780","journal-title":"Front Cardiovasc Med"},{"key":"5275_CR17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page\u00a0MJ, McKenzie\u00a0JE, Bossuyt\u00a0PM, Boutron\u00a0I, Hoffmann\u00a0TC, Mulrow\u00a0CD et\u00a0al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"1","key":"5275_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani\u00a0M, Hammady\u00a0H, Fedorowicz\u00a0Z, Elmagarmid\u00a0A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5(1):210","journal-title":"Syst Rev"},{"key":"5275_CR19","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne\u00a0JAC, Savovi\u0107\u00a0J, Page\u00a0MJ, Elbers\u00a0RG, Blencowe\u00a0NS, Boutron\u00a0I et\u00a0al (2019) RoB 2: a\u00a0revised tool for assessing risk of bias in randomised trials. BMJ 28:l4898","journal-title":"BMJ"},{"key":"5275_CR20","doi-asserted-by":"publisher","unstructured":"Page MJ, Higgins JP, Sterne JA Assessing risk of bias due to missing results in a\u00a0synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et\u00a0al (eds) Cochrane Handbook for Systematic Reviews of Interventions, pp\u00a0349\u2013374 https:\/\/doi.org\/10.1002\/9781119536604.ch13","DOI":"10.1002\/9781119536604.ch13"},{"issue":"7109","key":"5275_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger\u00a0M, Smith\u00a0GD, Schneider\u00a0M, Minder\u00a0C (1997) Bias in meta-analysis detected by a\u00a0simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"key":"5275_CR22","doi-asserted-by":"crossref","unstructured":"Zang X, Zhao Z, Chen K, Song W, Ma J, Zhou Y et\u00a0al (2023) Evaluation of the Efficacy of Sacubitril\/Valsartan on Radiofrequency Ablation in Patients with Hypertension and Persistent Atrial Fibrillation. Cardiovasc Drugs Ther 7:","DOI":"10.21203\/rs.3.rs-2738065\/v1"},{"issue":"1","key":"5275_CR23","first-page":"32","volume":"3","author":"R Cappato","year":"2010","unstructured":"Cappato\u00a0R, Calkins\u00a0H, Chen\u00a0SA, Davies\u00a0W, Iesaka\u00a0Y, Kalman\u00a0J et\u00a0al (2010) Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation. Circ: Arrhythmia Electrophysiol 3(1):32\u201338","journal-title":"Circ: Arrhythmia Electrophysiol"},{"issue":"10","key":"5275_CR24","first-page":"800","volume":"8","author":"KF Docherty","year":"2020","unstructured":"Docherty\u00a0KF, Vaduganathan\u00a0M, Solomon\u00a0SD, McMurray\u00a0JJV (2020) Sacubitril\/Valsartan. JACC: Heart Fail 8(10):800\u2013810","journal-title":"JACC: Heart Fail"},{"issue":"11","key":"5275_CR25","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.115.018622","volume":"133","author":"SA Hubers","year":"2016","unstructured":"Hubers\u00a0SA, Brown\u00a0NJ (2016) Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition. Circulation 133(11):1115\u20131124","journal-title":"Circulation"},{"issue":"3","key":"5275_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/jch.14120","volume":"23","author":"DS-H Lin","year":"2021","unstructured":"Lin\u00a0DS\u2011H, Wang\u00a0T, Buranakitjaroen\u00a0P, Chen\u00a0C, Cheng\u00a0H, Chia\u00a0YC et\u00a0al (2021) Angiotensin receptor neprilysin inhibitor as a\u00a0novel antihypertensive drug: Evidence from Asia and around the globe. J\u00a0of Clinical Hypertension 23(3):556\u2013567","journal-title":"J of Clinical Hypertension"},{"key":"5275_CR27","doi-asserted-by":"publisher","first-page":"877237","DOI":"10.3389\/fmed.2022.877237","volume":"9","author":"L Gan","year":"2022","unstructured":"Gan\u00a0L, Lyu\u00a0X, Yang\u00a0X, Zhao\u00a0Z, Tang\u00a0Y, Chen\u00a0Y et\u00a0al (2022) Application of Angiotensin Receptor-Neprilysin Inhibitor in Chronic Kidney Disease Patients: Chinese Expert Consensus. Front Med 9:877237","journal-title":"Front Med"},{"issue":"4","key":"5275_CR28","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10557-021-07174-2","volume":"35","author":"WH Cheng","year":"2021","unstructured":"Cheng\u00a0WH, Lugtu\u00a0IC, Chang\u00a0SL, Liu\u00a0SH, Chen\u00a0SA, Lo\u00a0LW (2021) Effects of Angiotensin Receptor-Neprilysin Inhibitor in Arrhythmogenicity Following Left Atrial Appendage Closure in an Animal Model. Cardiovasc Drugs Ther 35(4):759\u2013768 (Aug)","journal-title":"Cardiovasc Drugs Ther"},{"issue":"16","key":"5275_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms22168994","volume":"22","author":"H Sutanto","year":"2021","unstructured":"Sutanto\u00a0H, Dobrev\u00a0D, Heijman\u00a0J (2021) Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias. Int J Mol Sci 22(16):20","journal-title":"Int J Mol Sci"}],"updated-by":[{"DOI":"10.1007\/s00059-024-05283-w","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000}}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-024-05275-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-024-05275-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-024-05275-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:46:44Z","timestamp":1748951204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-024-05275-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5275"],"URL":"https:\/\/doi.org\/10.1007\/s00059-024-05275-w","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In this article the affiliation details for Author Fernando Ba\u00eda Bezerra were incorrectly given as Affiliation\u00a01 \u201cAnhembi Morumbi University, S\u00e3o Jos\u00e9 Dos Campos, Brazil\u201d and Affiliation\u00a09 \u201cJardim Das Colinas. S\u00e3o Jos\u00e9 Dos Campos, Brazil\u201c, but should have been only Affiliation\u00a01 \u201cAnhembi Morumbi University, Avenida Deputado Benedito Matarazzo, 6070 \u2013 Jardim Aquarius, S\u00e3o Jos\u00e9 Dos Campos \u2013 SP, 12230-002, Brazil\u201c. Also the ORCiD 0009-0007-2587-4176 for author Fernando Ba\u00eda Bezerra was inadvertently omitted.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An Erratum to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00059-024-05283-w","URL":"https:\/\/doi.org\/10.1007\/s00059-024-05283-w","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"F.\u00a0Ba\u00eda Bezerra, L.E.\u00a0Rodrigues Sobreira, V.K.\u00a0Tsuchiya Sano, A.\u00a0de Oliveira Macena L\u00f4bo, J.H.\u00a0Cavalcanti Orestes Cardoso, F.\u00a0Alves Kelly, F.C.\u00a0Aquino de Moraes, and F.M.\u00a0Consolim-Colombo declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}